495 related articles for article (PubMed ID: 27986346)
1. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
3. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
[TBL] [Abstract][Full Text] [Related]
4. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
Giantsoudi D; Adams J; MacDonald S; Paganetti H
Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
[TBL] [Abstract][Full Text] [Related]
5. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
[TBL] [Abstract][Full Text] [Related]
6. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
7. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
[TBL] [Abstract][Full Text] [Related]
8. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
9. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
[TBL] [Abstract][Full Text] [Related]
10. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.
Haas-Kogan D; Indelicato D; Paganetti H; Esiashvili N; Mahajan A; Yock T; Flampouri S; MacDonald S; Fouladi M; Stephen K; Kalapurakal J; Terezakis S; Kooy H; Grosshans D; Makrigiorgos M; Mishra K; Poussaint TY; Cohen K; Fitzgerald T; Gondi V; Liu A; Michalski J; Mirkovic D; Mohan R; Perkins S; Wong K; Vikram B; Buchsbaum J; Kun L
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):152-168. PubMed ID: 29619963
[TBL] [Abstract][Full Text] [Related]
11. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation.
Toussaint L; Indelicato DJ; Holgersen KS; Petersen JBB; Stokkevåg CH; Lassen-Ramshad Y; Casares-Magaz O; Vestergaard A; Muren LP
Acta Oncol; 2019 Oct; 58(10):1451-1456. PubMed ID: 31303090
[No Abstract] [Full Text] [Related]
12. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
14. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
[TBL] [Abstract][Full Text] [Related]
15. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
16. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
18. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
[TBL] [Abstract][Full Text] [Related]
19. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
Peeler CR; Mirkovic D; Titt U; Blanchard P; Gunther JR; Mahajan A; Mohan R; Grosshans DR
Radiother Oncol; 2016 Dec; 121(3):395-401. PubMed ID: 27863964
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
